JO
BDTX icon

John Overdeck’s Black Diamond Therapeutics BDTX Stock Holding History

John Overdeck’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.7K Sell
42,000
-1,300
-3% -$3.18K ﹤0.01% 4919
2026
Q1 		$92.2K Buy
+43,300
New +$103K ﹤0.01% 4394
2024
Q4 		– Sell
-84,200
Closed -$366K – 3218
2024
Q3 		$366K Sell
84,200
-99,027
-54% -$539K ﹤0.01% 2597
2024
Q2 		$854K Sell
183,227
-174,837
-49% -$939K ﹤0.01% 2076
2024
Q1 		$1.82M Sell
358,064
-9,229
-3% -$37.2K ﹤0.01% 1554
2023
Q4 		$1.03M Buy
367,293
+287,169
+358% +$674K ﹤0.01% 2052
2023
Q3 		$230K Buy
+80,124
New +$295K ﹤0.01% 2589
2023
Q2 		– Sell
-107,754
Closed -$204K – 3009
2023
Q1 		$204K Sell
107,754
-35,910
-25% -$82.5K ﹤0.01% 2548
2022
Q4 		$259K Sell
143,664
-64,229
-31% -$116K ﹤0.01% 2298
2022
Q3 		$351K Sell
207,893
-52,591
-20% -$162K ﹤0.01% 1912
2022
Q2 		$641K Sell
260,484
-146,939
-36% -$342K ﹤0.01% 1722
2022
Q1 		$1.13M Buy
407,423
+106,421
+35% +$389K ﹤0.01% 1656
2021
Q4 		$1.6M Buy
301,002
+4,196
+1% +$29.3K ﹤0.01% 2122
2021
Q3 		$2.51M Sell
296,806
-117,381
-28% -$1.16M 0.01% 1772
2021
Q2 		$5.05M Buy
414,187
+291,421
+237% +$5.76M 0.01% 1200
2021
Q1 		$2.98M Sell
122,766
-3,374
-3% -$91K 0.01% 1395
2020
Q4 		$4.04M Buy
+126,140
New +$4.14M 0.01% 1053

Other funds holding BDTX

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

John Overdeck's BDTX Position: Q2 2026 in Review

John Overdeck reduced its Black Diamond Therapeutics (BDTX) stake by 3% in Q2 2026, selling an estimated $3.18K and leaving 42,000 shares worth $77.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4919.

John Overdeck first reported a position in BDTX in Q4 2020 and has held it in 17 quarters since. The position peaked at $5.05M in Q2 2021. 96 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • John Overdeck held 42,000 shares of Black Diamond Therapeutics worth $77.7K as of Q2 2026.
  • John Overdeck sold 1,300 Black Diamond Therapeutics shares in Q2 2026, an estimated $3.18K.
  • Black Diamond Therapeutics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4919 holding.
  • John Overdeck first reported a position in Black Diamond Therapeutics in Q4 2020 and has held it in 17 quarters since.
  • John Overdeck's Black Diamond Therapeutics position peaked at $5.05M in Q2 2021.
  • 96 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.